Replies to post #545294 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

Thanks for asking. The comment that you’re asking me about appeared to be a general estimate to illustrate the typical case selection process for prestigious law firms with a track record of success in litigation. When you posed the question, I began to research the firm and I am finding that this legal action is more significant and more interesting than I thought before I looked at it. I will keep you posted on any interesting facts that I discover, but everyone can also do their own research about it.

https://www.cohenmilstein.com/sites/default/files/NWBO%20v.%20Canaccord%20et%20al%20-%20Complaint%2012012022%20-.pdf

https://www.cohenmilstein.com/



https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847

$nwbo Fact ✅ pic.twitter.com/WHI9D2fOrp

— Blake (@MC17595091) December 7, 2022